Transcripts
Johnson & Johnson to Review Interim Data from the Phase 1/2 RPGR Clinical Trial and Janssen's Retinal Portfolio Strategy (Pre-recorded) Transcript
2020-07-17Corporate Presentation
Read the full earnings transcript with Waltermetrics Pro
The complete transcript text is available to Pro members.
Upgrade to Pro